Athyrium Capital Management, LP

Investment Portfolio & 13F Holdings Analysis

About

Athyrium Capital Management, LP is an institutional investment manager that filed its latest Form 13F for 2024Q3, reporting 2 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-11-12
Total Holdings: 2
Total Value: 8686216
Accession Number: 0001123292-24-000336
Form Type: 13F-HR
CIK: 0001728001
Manager Name: Athyrium Capital Management, LP

Data Enrichment

50% identified

1 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

2 positions • $8,686.216K total value

2 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

74319F305

10929762(+0.0%)

Value:

$5.5B(-24.0%)

PUMA BIOTECHNOLOGY, INC.

PBYI|74587V107

1256411(+0.0%)

Value:

$3.2B(-21.8%)

Instrument	Shares		Other Manager	Value
(cusip74319F305)✕	10.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.5M	QoQ -24.00% (-$1.7M) YoY-
Puma Biotechnology, Inc.(PBYIcusip74587V107)	1.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$3.2M	QoQ -21.77% (-$892.1K) YoY-